Live
- India Faces Blow as Pacer Mohammed Shami Ruled Out for Remainder of Australia Series
- Farmer’s Day Celebrations Held at Palem Agricultural Research Center, Nagarkurnool
- Biden Pardon: Joe Biden Commutes Death Sentences of 37 Inmates, Including Child Killers and Mass Murderers
- South Korea: Yoon believes impeachment trial takes priority over martial law probe
- Strict Action for Non-Adherence to Time Management - DMHO Dr. Swarajya Lakshmi
- Joyful Semi-Christmas Celebrations at Sri Saraswathi International School
- Over 13.29 lakh houses approved for rural poor in Maharashtra: Shivraj Chouhan
- District Collector Urges Timely Completion of Indiramma Housing Scheme Survey
- Digital Arrest Scam: Hyderabad Man Duped of ₹7 Lakhs by Fake Crime Branch Police Callers
- Sukhbir Badal seeks President's Police medal for officer who saved his life
Dr Reddy's launches skin treatment drug in US
Highlights
Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.
New Delhi: Dr Reddy's Laboratories on Wednesday said it launched Daptomycin for injection, used for treating complicated skin infections, in the US market.
The company launched its product, which is generic version of Merck Sharp & Dohme Corp's Cubicin, after obtaining approval from the US Food and Drug Administration (USFDA), the pharma major said.
According to IQVIA Health, the Cubicin for injection (daptomycin for injection) brand and generics had sales of around $640.8 million for the most recent 12 months ending in March 2019.
Next Story
ADVERTISEMENT
